Saltar ao contenido
VuFind
English
Deutsch
Español
Français
Italiano
日本語
Nederlands
Português
Português (Brasil)
中文(简体)
中文(繁體)
Türkçe
עברית
Gaeilge
Cymraeg
Ελληνικά
Català
Euskara
Русский
Čeština
Suomi
Svenska
polski
Dansk
slovenščina
اللغة العربية
বাংলা
Galego
Tiếng Việt
Hrvatski
हिंदी
Հայերէն
Українська
Sámegiella
Монгол
Idioma
Todos os campos
Title
Autor
Subject
Número de Clasificación
ISBN/ISSN
Tag
Buscar
Avanzado
Biomarkers for Alzheimer's dis...
Citar
Text this
Enviar este rexistro por email
Imprimir
Exportar rexistro
Exportar a RefWorks
Exportar a EndNoteWeb
Exportar a EndNote
Permanent link
Biomarkers for Alzheimer's disease therapeutic trials
Show other versions (1)
Detalles Bibliográficos
Main Authors:
Hampel, H
,
Wilcock, G
,
Andrieu, S
,
Aisen, P
,
Blennow, K
,
Broich, K
,
Carrillo, M
,
Fox, N
,
Frisoni, G
,
Isaac, M
,
Lovestone, S
,
Nordberg, A
,
Prvulovic, D
,
Sampaio, C
,
Scheltens, P
,
Weiner, M
,
Winblad, B
,
Coley, N
,
Vellas, B
Formato:
Journal article
Publicado:
2010
Existencias
Descripción
Other Versions (1)
Títulos similares
Staff View
Mostrando
1 - 1
Resultados de
1
Show all versions (2)
Search Result 1
Biomarkers for Alzheimer's disease therapeutic trials.
por
Hampel, H
,
Wilcock, G
,
Andrieu, S
,
Aisen, P
,
Blennow, K
,
Broich, K
,
Carrillo, M
,
Fox, N
,
Frisoni, G
,
Isaac, M
,
Lovestone, S
,
Nordberg, A
,
Prvulovic, D
,
Sampaio, C
,
Scheltens, P
,
Weiner, M
,
Winblad, B
,
Coley, N
,
Vellas, B
Publicado 2011
Journal article
Show all versions (2)
Títulos similares
Biomarkers for Alzheimer's disease therapeutic trials.
por: Hampel, H, et al.
Publicado: (2011)
Endpoints for trials in Alzheimer's disease: a European task force consensus.
por: Vellas, B, et al.
Publicado: (2008)
Designing drug trials for Alzheimer's disease: what we have learned from the release of the phase III antibody trials: a report from the EU/US/CTAD Task Force.
por: Vellas, B, et al.
Publicado: (2013)
Disease-modifying trials in Alzheimer's disease: a European task force consensus.
por: Vellas, B, et al.
Publicado: (2007)
Methodological issues in primary prevention trials for neurodegenerative dementia.
por: Andrieu, S, et al.
Publicado: (2009)